Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
Doi, Toshihiko, Shitara, Kohei, Naito, Yoichi, Shimomura, Akihiko, Fujiwara, Yasuhiro, Yonemori, Kan, Shimizu, Chikako, Shimoi, Tatsunori, Kuboki, Yasutoshi, Matsubara, Nobuaki, Kitano, Atsuko, Jikoh, Takahiro, Lee, Caleb, Fujisaki, Yoshihiko, Ogitani, Yusuke, Yver, Antoine, Tamura, Kenji
Published in The lancet oncology (01.11.2017)
Published in The lancet oncology (01.11.2017)
Get full text
Journal Article
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
Makker, Vicky, Colombo, Nicoletta, Casado Herráez, Antonio, Santin, Alessandro D, Colomba, Emeline, Miller, David S, Fujiwara, Keiichi, Pignata, Sandro, Baron-Hay, Sally, Ray-Coquard, Isabelle, Shapira-Frommer, Ronnie, Ushijima, Kimio, Sakata, Jun, Yonemori, Kan, Kim, Yong Man, Guerra, Eva M, Sanli, Ulus A, McCormack, Mary M, Smith, Alan D, Keefe, Stephen, Bird, Steven, Dutta, Lea, Orlowski, Robert J, Lorusso, Domenica
Published in The New England journal of medicine (03.02.2022)
Published in The New England journal of medicine (03.02.2022)
Get full text
Journal Article
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial
Monk, Bradley J, Colombo, Nicoletta, Oza, Amit M, Fujiwara, Keiichi, Birrer, Michael J, Randall, Leslie, Poddubskaya, Elena V, Scambia, Giovanni, Shparyk, Yaroslav V, Lim, Myong Cheol, Bhoola, Snehalkumar M, Sohn, Joohyuk, Yonemori, Kan, Stewart, Ross A, Zhang, Xiaoxi, Perkins Smith, Julia, Linn, Carlos, Ledermann, Jonathan A
Published in The lancet oncology (01.09.2021)
Published in The lancet oncology (01.09.2021)
Get full text
Journal Article
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
Pujade-Lauraine, Eric, Fujiwara, Keiichi, Ledermann, Jonathan A, Oza, Amit M, Kristeleit, Rebecca, Ray-Coquard, Isabelle-Laure, Richardson, Gary E, Sessa, Cristiana, Yonemori, Kan, Banerjee, Susana, Leary, Alexandra, Tinker, Anna V, Jung, Kyung Hae, Madry, Radoslaw, Park, Sang-Yoon, Anderson, Charles K, Zohren, Fabian, Stewart, Ross A, Wei, Caimiao, Dychter, Samuel S, Monk, Bradley J
Published in The lancet oncology (01.07.2021)
Published in The lancet oncology (01.07.2021)
Get full text
Journal Article
High‐grade intraductal carcinoma of the parotid gland harboring CTNNA1::ALK rearrangement: Changes in genetic status using genetic testing during treatment with an ALK inhibitor
Watanabe, Takane, Honma, Yoshitaka, Yonemori, Kan, Sunami, Kuniko, Yoshimoto, Seiichi, Mori, Taisuke
Published in Head & neck (01.03.2024)
Published in Head & neck (01.03.2024)
Get full text
Journal Article
First‐in‐human study of ONO‐4578, an antagonist of prostaglandin E2 receptor 4, alone and with nivolumab in solid tumors
Iwasa, Satoru, Koyama, Takafumi, Nishino, Makoto, Kondo, Shunsuke, Sudo, Kazuki, Yonemori, Kan, Yoshida, Tatsuya, Tamura, Kenji, Shimizu, Toshio, Fujiwara, Yutaka, Kitano, Shigehisa, Shimomura, Akihiko, Sato, Jun, Yokoyama, Fumiharu, Iida, Hiroyuki, Kondo, Maki, Yamamoto, Noboru
Published in Cancer science (01.01.2023)
Published in Cancer science (01.01.2023)
Get full text
Journal Article
Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826
Nishio, Shin, Yonemori, Kan, Usami, Tomoka, Minobe, Shinichiro, Yunokawa, Mayu, Iwata, Takashi, Okamoto, Aikou, Aoki, Yoichi, Itamochi, Hiroaki, Takekuma, Munetaka, Harano, Kenichi, Yamamoto, Keiko, Maruko, Takeshi, Ugai, Hiroyuki, Tekin, Cumhur, Colombo, Nicoletta, Fujiwara, Keiichi, Hasegawa, Kosei, Ushijima, Kimio
Published in Cancer science (01.11.2022)
Published in Cancer science (01.11.2022)
Get full text
Journal Article
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial
Nishikawa, Tadaaki, Hasegawa, Kosei, Matsumoto, Koji, Mori, Masahiko, Hirashima, Yasuyuki, Takehara, Kazuhiro, Ariyoshi, Kazuya, Kato, Tomoyasu, Yagishita, Shigehiro, Hamada, Akinobu, Kawasaki, Mamiko, Kawashima, Satoshi, Tomatsuri, Sawako, Nagasaka, Yukari, Yoshida, Hiroshi, Machida, Ryunosuke, Hirakawa, Akihiro, Nakamura, Kenichi, Yonemori, Kan
Published in Journal of clinical oncology (20.05.2023)
Published in Journal of clinical oncology (20.05.2023)
Get full text
Journal Article
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study
Yonemori, Kan, Kuboki, Yasutoshi, Hasegawa, Kosei, Iwata, Takashi, Kato, Hidenori, Takehara, Kazuhiro, Hirashima, Yasuyuki, Kato, Hisamori, Passey, Chaitali, Buchbjerg, Jeppe Klint, Harris, Jeffrey R., Andreassen, Camilla Mondrup, Nicacio, Leonardo, Soumaoro, Ibrahima, Fujiwara, Keiichi
Published in Cancer science (01.08.2022)
Published in Cancer science (01.08.2022)
Get full text
Journal Article
Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice
Ida, Hanae, Koyama, Takafumi, Mizuno, Takaaki, Sunami, Kuniko, Kubo, Takashi, Sudo, Kazuki, Tao, Kayoko, Hirata, Makoto, Yonemori, Kan, Kato, Ken, Okusaka, Takuji, Ohe, Yuichiro, Matsui, Yoshiyuki, Yamazaki, Naoya, Ogawa, Chitose, Kawai, Akira, Narita, Yoshitaka, Esaki, Minoru, Yamamoto, Noboru
Published in Cancer science (01.12.2022)
Published in Cancer science (01.12.2022)
Get full text
Journal Article
Highly sensitive fusion detection using plasma cell‐free RNA in non‐small‐cell lung cancers
Hasegawa, Nobuhiko, Kohsaka, Shinji, Kurokawa, Kana, Shinno, Yuki, Takeda Nakamura, Ikuko, Ueno, Toshihide, Kojima, Shinya, Kawazu, Masahito, Suehara, Yoshiyuki, Ishijima, Muneaki, Goto, Yasushi, Kojima, Yuki, Yonemori, Kan, Hayashi, Takuo, Saito, Tsuyoshi, Shukuya, Takehito, Takahashi, Fumiyuki, Takahashi, Kazuhisa, Mano, Hiroyuki
Published in Cancer science (01.10.2021)
Published in Cancer science (01.10.2021)
Get full text
Journal Article
Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE‐775
Yonemori, Kan, Yunokawa, Mayu, Ushijima, Kimio, Sakata, Jun, Shikama, Ayumi, Minobe, Shinichiro, Usami, Tomoka, Enomoto, Takayuki, Takehara, Kazuhiro, Hasegawa, Kosei, Yamagami, Wataru, Yamamoto, Keiko, Han, Shirong, Dutta, Lea, Orlowski, Robert, Miura, Takuma, Makker, Vicky, Fujiwara, Keiichi
Published in Cancer science (01.10.2022)
Published in Cancer science (01.10.2022)
Get full text
Journal Article
Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy
Yoshida, Hiroshi, Nishikawa, Tadaaki, Matsumoto, Koji, Mori, Masahiko, Hirashima, Yasuyuki, Takehara, Kazuhiro, Ariyoshi, Kazuya, Hasegawa, Kosei, Yonemori, Kan
Published in Virchows Archiv : an international journal of pathology (01.06.2021)
Published in Virchows Archiv : an international journal of pathology (01.06.2021)
Get full text
Journal Article
First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors
Koyama, Takafumi, Shimizu, Toshio, Iwasa, Satoru, Fujiwara, Yutaka, Kondo, Shunsuke, Kitano, Shigehisa, Yonemori, Kan, Shimomura, Akihiko, Iizumi, Sakura, Sasaki, Tatsuya, Furuse, Junji, Yamamoto, Noboru
Published in Cancer science (01.02.2020)
Published in Cancer science (01.02.2020)
Get full text
Journal Article
Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510)
Nishikawa, Tadaaki, Kakunaga, Shigeki, Tamura, Kenji, Ando, Masashi, Ozaki, Toshifumi, Kawai, Akira, Ueda, Takafumi, Kawasaki, Mamiko, Tomatsuri, Sawako, Okamura, Nobuko, Kamikura, Masahisa, Hamada, Akinobu, Yoshida, Akihiko, Hirakawa, Akihiro, Shibata, Taro, Nakamura, Kenichi, Yonemori, Kan
Published in Cancer (15.11.2024)
Published in Cancer (15.11.2024)
Get full text
Journal Article
Phase I study of palbociclib, a cyclin‐dependent kinase 4/6 inhibitor, in Japanese patients
Tamura, Kenji, Mukai, Hirofumi, Naito, Yoichi, Yonemori, Kan, Kodaira, Makoto, Tanabe, Yuko, Yamamoto, Noboru, Osera, Shozo, Sasaki, Masaoki, Mori, Yuko, Hashigaki, Satoshi, Nagasawa, Takashi, Umeyama, Yoshiko, Yoshino, Takayuki
Published in Cancer science (01.06.2016)
Published in Cancer science (01.06.2016)
Get full text
Journal Article
320 Clinical significance of mesothelin expression and its correlation with HER2 in gynecologic carcinosarcoma
Kitadai, Rui, Nishikawa, Tadaaki, Yoshoda, Hiroshi, Mizoguchi, Chiharu, Saito, Ayumi, Yamamoto, Kasumi, Yazaki, Shu, Kojima, Yuki, Ishikawa, Mitsuya, Kato, Tomoyasu, Yonemori, Kan
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor‐positive advanced breast cancer
Tamura, Kenji, Kodaira, Makoto, Shimizu, Chikako, Yonemori, Kan, Yunokawa, Mayu, Shimomura, Akihiko, Kobayashi, Takayuki, Nakano, Kenji, Tomomatsu, Junichi, Ito, Yoshinori, Tanaka, Jun, Kuriki, Hiroshi, Gu, Zhaodi, Takahashi, Shunji
Published in Cancer science (01.05.2018)
Published in Cancer science (01.05.2018)
Get full text
Journal Article